International Clinical Trial: Clinical Study to Evaluate Safety, tolerability and efficacy of FDC of Timolol 0.5%, Brimonidine 0.2% and Brinzolamide 1% eye drops in patients with Glaucoma

Geneva, May 4 -- International Clinical Trials Registry received information related to the study (CTRI/2026/04/109312) titled 'Clinical Study to Evaluate Safety, tolerability and efficacy of FDC of Timolol 0.5%, Brimonidine 0.2% and Brinzolamide 1% eye drops in patients with Glaucoma' on April 24.

Study Type: PMS

Study Design: Single Arm Study Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Not Applicable

Primary Sponsor: Micro Labs Limited

Condition: Health Condition 1: H401- Open-angle glaucoma

Intervention: Intervention1: FDC of Timolol 0.5%, Brimonidine 0.2% and Brinzolamide 1% eye drops.: Instill one drop twice daily in the affected eye(s) ar...